Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
1961 • 2,448 citations
Classification and pharmacology of progestins
2003 • 712 citations
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
2000 • 372 citations
Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity
2004 • 173 citations
Source localization of androgen excess in adolescent girls.
1994 • 85 citations
Flutamide-Metformin Plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Early, Low-Dose Flutamide
2004 • 61 citations
Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome
2003 • 55 citations
Flutamide-Metformin Therapy to Reduce Fat Mass in Hyperinsulinemic Ovarian Hyperandrogenism: Effects in Adolescents and in Women on Third-Generation Oral Contraception
2003 • 45 citations